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GI Simulation Methods
• Dispersion Model
– Ho, NFH and Higuchi, WI - 1983
• Compartmental Absorption & Transit (CAT)
– Yu, LX and Amidon, GL - 1996
• Heterogeneous Tube Model
– Kalampokis, A and Macheras, P - 1999
• Advanced CAT Model (ACAT)
– Simulations Plus, Inc. – 1998 - 2006
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Data Integration Tool
GastroPlus is a state-of-the-art database and 
simulation computer program that contains the 
following elements:
– Differential equations
• Oral Absorption and related phenomena
– Release, dissolution, precipitation
– Transit
– Absorption – passive diffusion and carrier-mediated 
transport
• Pharmacokinetics
– Gut and liver metabolism
– Physiologically based pharmacokinetics
• Pharmacodynamics
– Direct and indirect models
– Solubility-pH calculation
– Selection of different physiologies
– Numerical integration
– Numerical optimization
– Plotting and file output
– Database and support files













Gut wall metabolism 
Blood
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=  transit,  Kt (i) = 1/transit time (i) 
= controlled  release,   Kr ∝ dose * time-release profile
= dissolution,  Kd (i) = 3 γ (CS  - CL) / (ρ r2 )
ρ = particle density
r = initial particle radius
Advanced  Compartmental  
Absorption  and  Transit  
(ACAT)  Model
=  absorption,  Ka (i) = α(i)Peff(i) α =  f(S,V) 
S = surface  area    V  =  volume
γ = diffusion coefficient CS(pH)  = solubility @ local pH
CL = concentration in lumen




In vitro enzyme kinetic 
constants Vmax(s) and Km(s)
Scaling to in 
vivo clearance
Fb + nonlinear kinetics
Physical 












PKPlus™- Vd, CL, 
K12, K21
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Example 1 Inputs
• MWt = 350
• logP = 2.5
• pKa = acid 5.5
• Solubility = 0.1 mg/mL @ 
pH 2
• Solubility factor = 500
• Effective permeability = 
2E-4 cm/s
• Dose = 100 mg tablet
• Particle density = 1.2 g/cc
• Particle radius = 25 
micron
• Diffusion coefficient = ??
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*Log P = 6.57
*Native Solubility = 0.069 μg/mL
*Permeability = 12 x 10-4 cm/s
Fraction Absorbed = 100%
*estimated by ADMET Predictor
LAB687
Log P = 4.7
Native Solubility = 0.17 μg/mL










– GPEN, Kansas, 2006
LAB687 Toremifene
SolFactor = 7.8x104 SolFactor=1.2x105
6
– GPEN, Kansas, 2006
Absorption - Fick’s First Law
• Absorption means crossing the apical 
membrane of the enterocytes (not entering 
the portal vein)
• Diffusion of molecules through a membrane 
results from a difference in concentration 
across the membrane
• For passive diffusion, molecules move in 
both directions, but the net flux is from high 
to low concentration, and is proportional to 
the concentration difference (unless 
electrochemical charge is involved)
• For intestinal absorption, D is proportional to 




J = D (Chi-Clo)
Clo Chi
J
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Rate of absorption based on:  Permeability =
f(Surface Area, Physico-chemical Properties, Transporters, and Efflux)
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Absorption term in compartment number i:
dMdiss(i)/dt = α(i) Peff(i) Vlum(i) (C(t)lum(i) – C(t)ent(i))
α(i) = absorption scale factor in compartment i (nominal value is 
surface/volume, which is 2/Ri)
Ri = radius of compartment i
Peff(i) = permeability in compartment i*
Vlum(i) = volume of lumen for compartment i
C(t)lum(i) = lumen concentration in compartment i
C(t)ent(i) = enterocyte concentration in compartment i
* permeability may be net, or only passive component
Absorption
ka'             Mdiss(i)
Ri
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pKa = 4.3 (Acid)
Duod J1       J2       I1       I2       I3        I4   Colon
6        6.2      6.4     6.6      6.8     7.2       7.5   5
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Simulations Plus log D Model
• Log(PeffpH)=a Δlog DpH +log(Peff0)   (1)
– Where: Δlog DpH = log P - logDpH
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Ungell, A.L., et al., 1998, J. Pharm. Sci. 87:360-366
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Rabbit Isolated Tissue Permability
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NH2 Fa = 25%
logD(6.5) = -3.3
Peff(7)=0.12
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Rate of solution of solid substances in 
their own solution
Noyes, AA and Whitney, WR, J. Am. Chem. Soc. 19:930-934 (1897)
“The rate at which a substance dissolves in its own solution is
proportional to the difference between the concentration of that





x=Concn. at time t
S=Solubility
C=Constant
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Solubility = 38.7 mM






















S = solubility    kd = dissolution rate constant (m-1)
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Dissolution/precipitation processes are defined by the 
rate constants k(i)d and k(i)p
CS  > CL => dissolution
CS  < CL => precipitation
=   Dissolution
=   Precipitation
γ = diffusion coefficient                  ρ = particle density 
r = initial particle radius                  T = diffusion layer thickness
CS(pH)  = solubility @ local pH
CL = concentration in lumen            tp= mean precipitation time
Dissolution and Precipitation
Nernst & Brunner (1904)
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Dissolution with Particle Size Distribution
• Particles are divided into n bins (n <= 16)
• Each bin is represented with a mean radius and a fraction of the total 
mass of solid particles at any instant
• Distribution can be normal, log-normal, or user-provided (.psd file)
• Smaller particles dissolve faster, increasing drug concentration
• Particles in each bin become smaller with time
• Each ACAT gut compartment has n bins, so if 16 bins are used with 9 
gut compartments, a total of 9*16= 144 differential equations for 
dissolution must be integrated – simulation runs slower
• Precipitation can cause particles to grow
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Fa = f(Permeability and Solubility)
Hendriksen BA, Sanchez MF, and Bolger MB: (2003). AAPS Pharm. Sci. 5(1):Article 4, 2003
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Zhao & Abraham Dataset
• Selected 238 compounds and converted SMILES 
to 3D with CORINA.
• Used ADMET Predictor to generate pKas.
• Used ADMET Predictor to generate estimates for 
Permeability, Solubility, and Diffusivity.
• Sub-classified into groups for passive absorption 
and transport via influx or efflux transporters.
• Calculated fraction absorbed using GastroPlus.
Zhao Y.H., J. Pharm. Sci. 90(6):749 (2001)
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GastroPlus Simulation Results
115 Comp. Calib: Simple Peff and Meylan Sw
84% within 25% of observed






















Sw > 8 ug/mL
Sw <= 8 ug/mL
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36 Active Transport
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• Human Physiological Fasted
• Human Physiological Fed
• Human Equal Transit Time 
Fasted
• Human Equal Transit Time Fed
• Beagle Dog Fasted
• Beagle Dog Fed
• Rat Fasted
• Mouse Fasted









• SI length & radius
• Stomach volume
• Colon volume
• Hepatic blood flow rate
• Gut enzyme and 
transporter distributions
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What experiments need to be run for a compound, and 
which ones can be skipped or delayed until we’re sure 
we need them?
– Sensitivity analysis identifies critical experimental 
parameters
• pKa measurements (vs predictions)
• permeability measurements – PAMPA, Caco-2, MDCK
• solubility measurements (vs predictions) – PBS vs FASSIF, 
FESSIF
– Toxicity experiments
• no need to run if compound can be eliminated for other 
reasons
• if needed, what dose levels to use (and which can be 
eliminated) in dose escalation studies in animals
Parameter Sensitivity Analysis
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– Hepatic blood flow?
Parameter Sensitivity Analysis (PSA)









25 micron radius 5 micron radius
17
– GPEN, Kansas, 2006
Neurosteroid Sim/PK/PD Methods
• ADMET PredictorTM - 3D strucs. used to estimate:
– Peff, Solubility, pKa, Diffusivity, log P
• GastroPlusTM used to simulate:
– Fraction absorbed
– Plasma concentration vs. time profile
– Pharmacodynamic response vs. time profile
• MS-Excel pivot table used to create 3D plot of log IC50
vs. log Sw vs. Maximal Response
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Neuroactive Steroid SAR
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Activity vs. BioPharm.
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Activity vs. BioPharm.
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PD Profile for most potent drug 
IC50 = 4.7 nM Sol. = 0.000058 mg/mL
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PD Profile for most effective drug 
IC50 = 104 nM Sol. = 0.046 mg/mL
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3D ADME Surface for 135 Neuroactive Steroids
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Conclusions
• Data integration is a key factor in drug 
discovery and development.
• Gastrointestinal simulation provides us with 
a mechanistic understanding of preclinical 
and clinical data.
• Parameter sensitivity is more important than 
the exact solution.
• Most potent compound is not always the 
best drug.
